Meet the Investigators

Meet the Investigators: Researchers who study lung cancer.

These scientists dedicate their professional lives to the study of lung cancer. The name for these scientists is “investigators.” Some Lung Cancer Investigators look for new medicines for lung cancer. Some look for ways to recognize lung cancer earlier. All work to find ways to help lung cancer patients live longer, fuller lives.

Some of the investigators here specialize in small cell lung cancer. They are working to find new treatments for better small cell lung cancer survival rates.

Other investigators here specialize in non-small cell lung cancer. Adenocarcinoma and Squamous Cell Carcinoma are both types of non-small cell lung cancer. Some investigators are working to find new treatments to “target” mutational changes in cancer cells. These mutational changes include ALK, EGFR, ROS1, BRAF  and more.

There are also investigators listed here who work in the field of immunotherapy. Immunotherapy is the latest exciting research breakthrough for lung cancer. Immunotherapies stimulate or use a person’s own immune system to attack cancer cells. In recent years, the FDA has approved several immunotherapies to be used to treat lung cancer, with more in the pipeline awaiting approval.

Among this group of dedicated scientists, are investigators who have been recipients of research grants awarded by Lung Cancer Foundation of America. These investigators presented the “best science” proposal to LCFA’s Scientific Advisory Board and were chosen to receive a significant lung cancer research grant.

Each of these scientists has a unique story. Watch these videos as they explain how their research helps lung cancer patients and the families and caregivers who support them.

Thanks to our generous sponsors

Novartis logoBristol-Myers Squibb logoGenentech logo